AJANTA PHARMA LIMITED vs CIPLA LTD
A side-by-side comparison of AJANTA PHARMA LIMITED (AJANTPHARM) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
AJANTA PHARMA LIMITED vs CIPLA LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation13
- Profitability40
- Growth20
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
CIPLA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
AJANTPHARM takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
AJANTPHARM takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
CIPLA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 25.2%", "Company has been maintaining a healthy dividend payout of 50.1%"]
- − ["Stock is trading at 9.82 times its book value", "Promoter holding has decreased over last quarter: -2.76%"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.